Exosome Medical

CORE TECHNOLOGY

iPS-Derived Exosomes

What Are iPS Exosomes?

iPS Exosomes are extracellular vesicles secreted by induced pluripotent stem cells (iPSCs). These nano-sized particles (30-150nm) carry proteins, lipids, and nucleic acids that can influence cellular behavior.

iPSCs, which are expected to be used in regenerative medicine, are being researched worldwide. The exosomes derived from these cells have shown promising results in numerous cell and animal experiments.

Unlike cell-based therapies, exosomes offer a cell-free approach that may provide similar regenerative benefits with improved safety profiles.

Key Cellular Benefits of iPSC-Derived Exosomes

Key Cellular Benefits

Research has demonstrated multiple beneficial effects of iPSC-derived exosomes on cellular health.

Reduce Cellular Aging

Delay senescence, maintain cell vitality, and lower β-galactosidase levels associated with aging.

Protect from UV Damage

Preserve cell numbers and collagen production under UV exposure stress.

Maintain Collagen Production

Support ongoing collagen synthesis essential for tissue structure and skin health.

Maintain Vascular Structure

Protect vascular cells under sugar stress, supporting cardiovascular health.

Support Cell Proliferation

Restore cellular proliferation rates, outperforming MSC-derived exosomes in studies.

Enhanced Regeneration

Promote tissue repair and regeneration through targeted molecular signaling.

Cell reprogramming and telomere restoration

Why iPS-Derived?

Induced Pluripotent Stem Cells (iPSCs) are adult cells reprogrammed back to an embryonic-like state. This process restores youthful cellular characteristics, including telomere length.

As we age, our telomeres shorten, contributing to cellular aging and reduced regenerative capacity. iPS cells essentially "reset" this aging clock.

Scalability
100%
Consistency
0
Ethical Issues

Virus-Free iPS Cells

Typically, iPS cells are generated by introducing reprogramming factors into somatic cells using gene introduction methods or viral methods. These methods carry the risk of genetic recombination.

Our iPS cells are established using a next-generation method utilizing mRNA, which eliminates the risk of genetic recombination or residual viruses.

mRNA Method: Because mRNA does not persist in the cells, it will not contaminate the culture supernatant or mix into the exosomes.

Traditional vs mRNA Method

Viral Methods

Risk of genetic recombination

Gene Introduction

Potential contamination

mRNA Method

No genetic risk, no contamination

Quality & Compliance

Our exosomes meet the strict regulatory standards of Japan, the US, and Europe.

GMP-Compliant Facility

The facilities are established for the manufacturing of cell products for regenerative medicine, with strictly defined standards for cleanliness, management methods, and manufacturing procedures.

  • Monitoring airborne particulates and bacteria
  • Frequent cleaning and periodic inspections
  • Only trained personnel perform the work

Multi-Step Purification

Our iPS Exosomes are purified multiple times to remove components other than exosomes, such as those originally contained in the culture medium and cell waste products.

  • Strict donor screening protocols
  • Multiple tests at different time points
  • High-concentration final product

Learn More About Our Research

Explore our published research or contact us for collaboration opportunities.